Fertility and Temporality in Pediatric Oncology
FERTITOP
1 other identifier
observational
300
1 country
5
Brief Summary
Background: When a cancer is diagnosed in a child, the urgency is to take therapeutic actions. Children and their families face the reality of cancer and the reality of the treatments that, in addition to be overwhelming, might cause infertility. Immediately after the diagnosis, a fertility preservation consultation is proposed to discuss fertility preservation options. In practice, it is often difficult to organize. Several years after the end of treatments, a second information consultation is proposed to inform about fertility, evaluate the fertility status and propose a second line of Fertility Preservation when possible. The literature reflects a lack of knowledge regarding the degree of fertility-related distress among pediatric cancer patients as well as insufficient tools at the disposal of medical doctors and nurses to discuss about reproduction with children and young adolescents. Project objective: Understand how young cancer patients and their parents felt about sterility risk at the diagnostic time and now as cured adolescents. Patients \& Methods: 300 patients (15-25 years) from 5 different centers (20 patients per year and per center for 3 years) will be included in this study at the information consultation. They will be surveyed through self-administered questionnaires and semidirected interviews that will 1) retrieve perceptions and emotional being of children during the fertility preservation consultation; 2) assess the decision-making process of parents and family since the fertility preservation consultation through the patient's speech; 3) interview the patients about personal history and experience of cancer and consequences of potential fertility impairment and 4) survey the current experience and projections in the future and evaluate their reaction to the proposition of a second line of Fertility Preservation. Expected results: what points should the doctor / psychologist discuss with pediatric cancer survivors in response to their fertility stress? and how to do it? for better initial and follow-up care to improve their quality of life after cancer.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2021
Typical duration for all trials
5 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 25, 2021
CompletedStudy Start
First participant enrolled
September 1, 2021
CompletedFirst Posted
Study publicly available on registry
September 17, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2024
CompletedSeptember 17, 2021
September 1, 2021
2.2 years
August 25, 2021
September 8, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Evaluate the impact of infertility on psychological health
Patients will report the outcomes of the infertility risks on the questionnaire provided in this study. Positive and negative impacts will be questioned.
december 2023
Secondary Outcomes (1)
Develop a decision aid tool for clinicians designed to increase referral for fertility preservation
december 2023
Study Arms (1)
FERTITOP
300 patients (15-25 years) from 5 different hospitals (University Hospitals of Nancy, Strasbourg, Reims, Besançon, Dijon (France)) who have finished all cancer treatments for at least 2 years.
Interventions
Patients will be surveyed through self-administered questionnaires and semidirected interviews with a psychologist
Eligibility Criteria
Adolescents and young adults treated for childhood cancer in one of the five hospital of the Great Est region or France having a follow-up by a pediatric oncologist.
You may qualify if:
- age between 15 -25
- having been diagnosed with cancer during childhood or adolescence,
- having finished the treatments and being in remission for at least 2 years
You may not qualify if:
- Recurrence of cancer at the time of the study
- Lack of cognitive autonomy to be able to agree to participate in the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Central Hospital, Nancy, Francelead
- National Cancer Institute, Francecollaborator
Study Sites (5)
University Hospital of Besançon
Besançon, France
University Hospital of Dijon
Dijon, France
University Hospital of Nancy, France
Nancy, 54000, France
University hospital of Reims
Reims, France
University hospital of Strasbourg
Strasbourg, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
August 25, 2021
First Posted
September 17, 2021
Study Start
September 1, 2021
Primary Completion
December 1, 2023
Study Completion
March 1, 2024
Last Updated
September 17, 2021
Record last verified: 2021-09